MicroRNA hepatocellular carcinoma detect: discriminant function based on a circulating panel of microRNA for accurate diagnosis of hepatocellular carcinoma patients on top hepatitis C virus infection | Synapse
March 3, 2026
MicroRNA hepatocellular carcinoma detect: discriminant function based on a circulating panel of microRNA for accurate diagnosis of hepatocellular carcinoma patients on top hepatitis C virus infection
Key Points
Detection rates for HCC are improved using the miR-HCC Detect score, which surpasses individual biomarker performance.
The analysis shows that circulating miRNAs serve as effective noninvasive biomarkers for hepatocellular carcinoma.
Assessment shows that hepatitis C virus infection status influences the diagnostic accuracy of the microRNA panel.
This study highlights the need for further validation of noninvasive diagnostic tools for early HCC detection.
Abstract
These circulating miRNAs represent promising noninvasive biomarkers for HCC detection in HCV-infected patients. The miR-HCC Detect score outperforms individual miRNAs and may improve early HCC surveillance.